Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for…
Medical - Diagnostics & Research
US, Redwood City [HQ]
GH/Financial Reporting
Income Statements
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.00 | 49.00 | 90.00 | 214.00 | 286.00 | 373.00 | 449.00 | 563.00 | |
|
EPS
|
-0.65 | -1.18 | -2.80 | -0.75 | -2.53 | -3.80 | -6.41 | -4.28 | |
| Diluted in mil. | -0.65 | -1.18 | -2.80 | -0.75 | -2.53 | -3.80 | -6.41 | -4.28 | |
|
Profit
|
3.00 | 18.00 | 47.00 | 143.00 | 194.00 | 250.00 | 293.00 | 336.00 | |
| Gross Margin | 12.38 | 36.56 | 52.33 | 67.01 | 67.73 | 67.11 | 65.23 | 59.74 | |
| Pre Tax | -46.00 | -83.00 | -84.00 | -69.00 | -245.00 | -384.00 | -653.00 | -478.00 | |
| Profit Margin | -182.71 | -166.96 | -92.92 | -32.52 | -85.76 | -102.89 | -145.36 | -84.90 | |
| ETR | -0.01 | -0.01 | -0.05 | 2.68 | -0.15 | -0.08 | -0.17 | -0.14 | |
| Net | -46.00 | -83.00 | -85.00 | -67.00 | -246.00 | -384.00 | -654.00 | -479.00 | |
| Profit Margin | -182.74 | -166.97 | -93.85 | -31.65 | -85.89 | -102.98 | -145.61 | -85.02 | |
| EBITDA | -39.00 | -70.00 | -82.00 | -68.00 | -241.00 | -381.00 | -650.00 | -519.00 | |
| EBITDA Margin | -156.13 | -140.91 | -91.54 | -31.97 | -84.10 | -102.21 | -144.79 | -92.14 | |
| Operating Income | -43.00 | -76.00 | -92.00 | -82.00 | -254.00 | -411.00 | -544.00 | -562.00 | |
| Operating Margin | -173.66 | -153.71 | -102.54 | -38.42 | -88.92 | -110.00 | -121.10 | -99.75 | |
| Interest Income | - - | 2.00 | 5.00 | 13.00 | 10.00 | 3.00 | 6.00 | 35.00 | |
| Loss | -69.00 | -126.00 | -183.00 | -296.00 | -541.00 | -784.00 | -993.00 | -1,126.00 | |
| Cost of Revenue | -22.00 | -31.00 | -43.00 | -70.00 | -92.00 | -122.00 | -156.00 | -227.00 | |
|
Operating Expenses
|
-46.00 | -94.00 | -140.00 | -226.00 | -449.00 | -661.00 | -837.00 | -899.00 | |
| R&D | -10.00 | -25.00 | -50.00 | -86.00 | -149.00 | -263.00 | -373.00 | -365.00 | |
| G&A | -9.00 | -36.00 | -36.00 | -61.00 | -192.00 | -206.00 | -163.00 | -155.00 | |
| SG&A | -36.00 | -69.00 | -89.00 | -139.00 | -299.00 | -398.00 | -463.00 | -449.00 | |
| S&M | -26.00 | -32.00 | -53.00 | -78.00 | -106.00 | -191.00 | -299.00 | -295.00 | |
| Depreciation and Amortization | -3.00 | -5.00 | -7.00 | -13.00 | -16.00 | -22.00 | -35.00 | -42.00 | |
| Interest Expenses | -3.00 | -2.00 | -1.00 | -1.00 | -4.00 | -2.00 | -2.00 | -2.00 | |
| Other Expenses | - - | -6.00 | -4.00 | -12.00 | -9.00 | -26.00 | -109.00 | -83.00 | |
|
WA Shares Outstanding
|
70.00 | 70.00 | 30.00 | 90.00 | 97.00 | 101.00 | 102.00 | 111.00 | |
| Diluted | 70.00 | 70.00 | 30.00 | 90.00 | 97.00 | 101.00 | 102.00 | 111.00 |